Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
9.55
-0.47 (-4.69%)
Nov 18, 2025, 12:49 PM EST - Market open
Vor Biopharma Market Cap
Vor Biopharma has a market cap or net worth of $194.92 million as of November 18, 2025. Its market cap has increased by 239.34% in one year.
Market Cap
194.92M
Enterprise Value
32.01M
1-Year Change
239.34%
Ranking
Category
Stock Price
$9.55
Market Cap Chart
Since the IPO on February 5, 2021, Vor Biopharma's market cap has decreased from $1.30B to $194.92M, a decrease of -85.00%. That is a compound annual growth rate of -32.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2025 | 204.51M | 47.94% |
| Dec 31, 2024 | 138.24M | -9.38% |
| Dec 29, 2023 | 152.56M | -65.05% |
| Dec 30, 2022 | 436.57M | 0.75% |
| Dec 31, 2021 | 433.30M | -66.64% |
| Feb 5, 2021 | 1.30B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 913.85B |
| Johnson & Johnson | 474.55B |
| AbbVie | 414.63B |
| UnitedHealth Group | 293.79B |
| AstraZeneca | 276.16B |
| Novartis AG | 252.58B |
| Merck & Co. | 232.29B |
| Abbott Laboratories | 227.95B |